AtriCure (Nasdaq:ATRC) today announced the successful first-in-human treatments using its novel dual-energy platform.
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...
Learn more about whether AtriCure, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether AtriCure, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback